Related Experiment Video
Updated: May 21, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Klotho inhibits the capacity of cell migration and invasion in cervical cancer
Boogi Chang1, Jinsun Kim, Dongjun Jeong
1Research Center for Women's Diseases and Department of Biological Sciences, Sookmyung Women's University, Seoul, Republic of Korea.
Abstract:
Aberrant activation of the Wnt/β-catenin signaling pathway is common in human cervical cancers. However, the mechanisms of Wnt activation in cervical cancer remain largely unknown. In the present study, we demonstrate that Klotho, a Wnt antagonist, is downregulated in invasive human cervical tumors and in a cell line we analyzed. Our data demonstrated that in vivo Klotho expression was not observed in invasive cervical carcinoma. In vitro restoration of Klotho expression in SiHa cells resulted in a decreased cell motility and invasiveness through upregulation of E-cadherin, downregulation of N-cadherin and reduced expression of MMP7 and -9. Ectopic expression of Klotho also reduced the expression of the epithelial-to-mesenchymal transition (EMT) transcription factors Slug and Twist. Furthermore, Klotho causes a significant inhibition of the Wnt/β-catenin pathway in cervical cancer cells, as supported by the expression of Wnt/β-catenin transcriptional target genes such as c-Myc and cyclin D1. Consequently, our findings demonstrate for the first time that Klotho regulates tumor invasion through the EMT process and provide novel mechanistic insights into the role of Klotho in cervical cancer progression and contribute to treatment for metastatic cervical cancer patients.
Insights
Klotho, a Wnt antagonist, is downregulated in cervical cancer, inhibiting tumor invasion and epithelial-to-mesenchymal transition (EMT). Restoring Klotho suppresses Wnt/β-catenin signaling, offering potential therapeutic strategies for metastatic cervical cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Aberrant Wnt/β-catenin signaling is implicated in human cervical cancers.
- The precise mechanisms driving Wnt activation in cervical cancer are not fully understood.
Purpose of the Study:
- To investigate the role of Klotho, a known Wnt antagonist, in cervical cancer progression.
- To elucidate the mechanisms by which Klotho influences cervical cancer cell behavior and Wnt pathway activity.
Main Methods:
- Analysis of Klotho expression in human cervical tumors and cell lines.
- In vitro restoration of Klotho expression in SiHa cervical cancer cells.
- Assessment of cell motility, invasiveness, epithelial-to-mesenchymal transition (EMT) markers, and Wnt/β-catenin pathway activity.
Main Results:
- Klotho expression is downregulated in invasive human cervical tumors and cell lines.
- Restoration of Klotho in SiHa cells reduced cell motility and invasiveness.
- Klotho suppressed EMT by altering E-cadherin, N-cadherin, MMP7, MMP9, Slug, and Twist expression.
- Klotho significantly inhibited the Wnt/β-catenin pathway, evidenced by reduced c-Myc and cyclin D1 expression.
Conclusions:
- Klotho downregulation contributes to cervical cancer progression by promoting tumor invasion via the EMT process.
- Klotho acts as a regulator of the Wnt/β-catenin pathway in cervical cancer.
- These findings offer novel insights into Klotho's role in cervical cancer and suggest its potential as a therapeutic target for metastatic disease.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Cancer Cell Migration through Invadopodia
Cell Migration
Cell Migration
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

